Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Zhenshiming Pharmaceutical Group and its related entities are established manufacturers of pharmaceutical products for ophthalmological use, with a focus on medicated and lubricating eye drops. Their products target dry eye syndrome and other ocular surface disorders. The company is recognized as a leading player in China's hypromellose/artificial tears segment, with commercialized offerings but no public clinical trial data typical of new drug development companies. Pipeline breadth and details are not publicly disclosed; the company appears to focus on marketed products rather than novel therapeutics in clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhenshiming Eye Health Industry.